Active monitoring for tiny papillary thyroid cancer
Part of Cancer, Hormones & metabolism clinical trials.
This study looks at whether closely watching (without immediate surgery or treatment) a very small thyroid cancer can be safe. You may benefit by avoiding unnecessary procedures, while the team monitors your thyroid and any changes over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a thyroid biopsy result that shows certain types of papillary thyroid cancer (or cells that strongly suggest it).
- Your thyroid nodule is 2.0 cm (about 0.8 inch) or smaller on ultrasound.
- If your biopsy was “Bethesda III or IV,” you must have a BRAF mutation.
- You must be able to read and write English to complete study questionnaires.
- You must be able to understand the study and sign consent forms (including privacy permission).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares three ways to manage small thyroid cancers (1 cm or less). It looks at whether surgery, a heat-based procedure to destroy the tumor, or simply watching it closely are all safe and keep quality of life high.
This trial is testing less invasive treatments for a very small, slow-growing type of thyroid cancer (papillary thyroid microcarcinoma). If you have this specific cancer and are a candidate for a non-surgical procedure, the study will check how well these treatments work.
This trial studies a treatment option for papillary thyroid microcarcinoma in adults who either do not want surgery or cannot safely have surgery. It may help people find a non-surgical approach for a very small thyroid cancer.
This study looks at whether microwave ablation, a minimally invasive treatment, works as well as surgery for small, low-risk thyroid cancers. It uses special ultrasound and genetic tests to help decide the best treatment.
This study tests whether taking thyroid hormone to lower TSH (a hormone that can stimulate thyroid cancer) is necessary for people with very small, low-risk thyroid cancers who choose active surveillance (monitoring instead of immediate surgery). It aims to find out if skipping this treatment is safe and helps avoid side effects.
This trial tests whether it is safe to avoid immediate surgery and instead monitor small thyroid cancers that are considered low-risk. If you join, doctors will check regularly to make sure the cancer does not grow or spread.
Hear when a new Papillary Thyroid Microcarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.